DiJoseph J, Khandke K, Dougher M, Evans D, Armellino D, Hamann P, Damle N. CMC-544 (inotuzumab ozogamicin): A CD22-targeted immunoconjugate of calicheamicin. Hematol Meeting Rep [Internet]. 2009 Jun. 23 [cited 2024 Jul. 22];2(5). Available from: https://www.pagepress.org/journals/hmr/article/view/735